Bryan C Fuchs
Harvard University
H-index: 47
North America-United States
Top articles of Bryan C Fuchs
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
P154 Histological disease progression and ALK5i therapeutic efficacy in a chronic DSS-induced mouse model of IBD with intestinal fibrosis | Journal of Crohn's and Colitis | MH Nielsen L Zachariassen AK Sárvári MR Madsen HB Hansen | 2024/1/1 |
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial | The Lancet Diabetes & Endocrinology | Parminder K Judge Natalie Staplin Kaitlin J Mayne Christoph Wanner Jennifer B Green | 2024/1/1 |
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial | The Lancet Diabetes & Endocrinology | N Staplin R Haynes PK Judge C Wanner JB Green | 2024/1/1 |
An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancer | JTCVS Open | Hexiao Tang Eric Abston Mozhdeh Sojoodi Yongtao Wang Derek J Erstad | 2024/2/1 |
Molecular MR imaging of renal Fibrogenesis in mice | Journal of the American Society of Nephrology | Yin-Ching Chen Philip A Waghorn Ivy A Rosales Gunisha Arora Derek J Erstad | 2023/7/1 |
699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION | Gastroenterology | Jessica R Allegretti Paul Feuerstadt Whitfield L Knapple Robert Orenstein Philippe Pinton | 2023/5/1 |
Human Fecal Bile Acid Analysis after Investigational Microbiota-Based Live Biotherapeutic Delivery for Recurrent Clostridioides difficile Infection | Microorganisms | Romeo Papazyan Nicky Ferdyan Karthik Srinivasan Carlos Gonzalez William D Shannon | 2023/1/5 |
Precision-Cut Liver Slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis | bioRxiv | Yongtao Wang Ben Leaker Guoliang Qiao Mozhdeh Sojoodi Ibrahim Ragab Eissa | 2023/11/5 |
pH dependence of a GPR4 selective antagonist hampers its therapeutic potential | Journal of Pharmacology and Experimental Therapeutics | Jacek Stalewski Amy Y Shih Romeo Papazyan Jocelyn Ramirez Gerardo Ibanez | 2023/7/1 |
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation | JCI insight | Emilie Crouchet Shen Li Mozhdeh Sojoodi Simonetta Bandiera Naoto Fujiwara | 2022/7/7 |
Peroxidasin deficiency recruits pro-healing macrophages into the liver and inhibits NAFLD progression to HCC | Cancer Research | Mozhdeh Sojoodi Stephen C Barrett Derek J Erstad Shadi Salloum Shijia Zhu | 2022/6/15 |
Su1596: microbiome and bile acid restoration was consistent across three clinical trials of rbx2660 for recurrent Clostridioides difficile infection: a combined analysis | Gastroenterology | Ken Blount Heidi Hau Romeo Papazyan Bryan Fuchs Bill Shannon | 2022/5/1 |
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity | Science translational medicine | Natascha Roehlen Antonio Saviano Houssein El Saghire Emilie Crouchet Zeina Nehme | 2022/12/21 |
Molecular signature predictive of long-term liver fibrosis progression to inform antifibrotic drug development | Gastroenterology | Tongqi Qian Naoto Fujiwara Bhuvaneswari Koneru Atsushi Ono Naoto Kubota | 2022/4/1 |
Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram | Frontiers in Oncology | Gong Zhang Yufeng Wang Bryan C Fuchs Wei Guo David L Drum | 2022/7/14 |
Peroxidasin deficiency re-programs macrophages toward pro-fibrolysis function and promotes collagen resolution in liver | Cellular and Molecular Gastroenterology and Hepatology | Mozhdeh Sojoodi Derek J Erstad Stephen C Barrett Shadi Salloum Shijia Zhu | 2022/1/1 |
Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis | Scientific Reports | Philip A Waghorn Diego S Ferreira Derek J Erstad Nicholas J Rotile Ricard Masia | 2021/3/17 |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance | Molecular Therapy-Oncolytics | Jennifer L Green Robin E Osterhout Amy L Klova Carsten Merkwirth Scott RP McDonnell | 2021/12/17 |
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma | Gut | Frank Juhling Nourdine Hamdane Emilie Crouchet Shen Li Houssein El Saghire | 2021/1/1 |
1039. rapid restoration of bile acid compositions after treatment with RBX2660 for recurrent clostridioides difficile infection—results from the PUNCH CD3 phase 3 trial | Open Forum Infectious Diseases | Romeo Papazyan Bryan Fuchs Ken Blount Carlos Gonzalez Bill Shannon | 2021/11 |
Co-Authors
